David Kirn owns 0.98% of 4D Molecular Therapeutics
709,153 shares as of the October 5, 2026 filing, worth $8.6M at the latest close.
FDMT · $876M market cap · Founder-ledGet an email when David Kirn’s stake moves.
Free.
The stake
0.98%
worth $8.6M at the latest close
Stake rank
#1,814
by dollar value of the stake
Last sale
14 days ago
Oct 5, 2026
Last buy
None
no purchases since 2022
David Kirn owns 0.98% of 4D Molecular Therapeutics, Inc.: 709,153 of 72,179,876 shares, worth about $8.6M at the 2026-10-16 close. The stake has moved from 7.49% in 2020 to 0.98% on 2026-10-05, across 14 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $753,937 on 2026-10-05.
How the stake is held
as of the Oct 5, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 5, 2026 · Form 4 ↗
HELD DIRECTLY
709,153
100.0%
THE STAKE
709,153
0.98%